ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF

Antibodies to human N3pGlu Aß, compositions comprising such N3pGlu Aß antibodies, and methods of using such N3pGlu Aß antibodies for the treatment of a disease characterized by deposition of Aß including clinical or pre-clinical Alzheimers disease, Downs syndrome, and clinical or pre-clinical cerebr...

Full description

Saved in:
Bibliographic Details
Main Authors Jirong LU, Ying TANG, Ronald Bradley DEMATTOS
Format Patent
LanguageEnglish
Spanish
Published 13.01.2020
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Antibodies to human N3pGlu Aß, compositions comprising such N3pGlu Aß antibodies, and methods of using such N3pGlu Aß antibodies for the treatment of a disease characterized by deposition of Aß including clinical or pre-clinical Alzheimers disease, Downs syndrome, and clinical or pre-clinical cerebral amyloid angiopathy. Anticuerpos anti-N3pGlu Aß humana, composiciones que comprenden tales anticuerpos anti-N3pGlu Aß, y métodos de uso tales anticuerpos anti-N3pGlu Aß para el tratamiento de una enfermedad caracterizada por la deposición de Aß que incluye la enfermedad de Alzheimer clínica o preclínica, síndrome de Down, y angiopatía amiloide cerebral clínica o preclínica.
Bibliography:Application Number: MX20190012445